Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.
Artificial intelligence (AI) is transforming the life sciences industry, with potentially its most significant impact on drug ...
The Mystra platform, developed over 10 years, offers biopharma partners proven analytical power to turn months of R&D into minutes, dramatically increasing the availability of quality genetic insights ...
Novartis has tapped up an artificial-intelligence-enabled British biotech for a $1.7 billion biobucks deal to discover new targets for immuno-dermatology conditions. What caught the Swiss pharma’s eye ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results